GSE143782 calcitriol 6 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE143782_calcitriol_6_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE143782_calcitriol_6_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE143782_calcitriol_6_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE143782_calcitriol_6_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 3

Gene

multidrug resistance-related protein

Gene

SLC16A1 antisense RNA 1

Gene

zinc finger domain-containing protein LOC728743

Gene

PRR34 antisense RNA 1

Gene

FOXD3 antisense RNA 1

Gene

sphingomyelin phosphodiesterase 4B, pseudogene

Gene

FAM222A antisense RNA 1

Gene

RCC2 antisense RNA 1

Gene

PDCD6-AHRR readthrough (NMD candidate)

  • Gene

    small nucleolar RNA host gene 3


  • Gene

    multidrug resistance-related protein


  • Gene

    SLC16A1 antisense RNA 1


  • Gene

    zinc finger domain-containing protein LOC728743


  • Gene

    PRR34 antisense RNA 1


  • Gene

    FOXD3 antisense RNA 1


  • Gene

    sphingomyelin phosphodiesterase 4B, pseudogene


  • Gene

    FAM222A antisense RNA 1


  • Gene

    RCC2 antisense RNA 1


  • Gene

    PDCD6-AHRR readthrough (NMD candidate)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.